低位直肠癌是否应采用短程新辅助放疗?随机试验的系统综述与荟萃分析
该研究系统检索并荟萃分析了比较短程放疗(SC,5×5 Gy)与长程放化疗(LC)的随机试验,聚焦于距肛缘<5 cm的低位直肠癌患者,共纳入4项试验、421例患者(SC组221例,LC组200例)。结论不支持LC在降低低位肿瘤局部失败风险上优于SC的观点。
要点
- 低位直肠癌(距肛缘<5 cm)中,SC与LC局部失败率差异无统计学意义。
- 结果不支持LC在确保低位肿瘤局部控制上优于SC的假设。
核心结论
- 荟萃分析不支持全直肠系膜切除术前LC在降低低位肿瘤局部失败风险上优于SC的观点。
研究设计与样本
- 系统综述与荟萃分析,纳入4项比较SC与LC的随机试验,共421例距肛缘<5 cm的直肠癌患者,SC组221例,LC组200例。
关键数值与推荐
- SC方案为5×5 Gy;LC为长程放化疗;低位肿瘤定义为距肛缘<5 cm。
临床怎么用
- 对于低位直肠癌,短程放疗可作为与长程放化疗等效的术前选择之一,局部控制无显著差异。
局限性
- 原文未报告纳入试验的具体偏倚风险、随访时长及总生存等结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: National Comprehensive Cancer Network guidelines recommend either long-course chemoradiation (LC) or short-course radiation (SC, 5 × 5 Gy) for rectal cancer before total mesorectal excision. However, they do not recommend SC for low-lying tumors. As early toxicity of SC is lower than that of LC, and postoperative complications as well as late toxicity are similar, the probable reason is a notion that for low-lying tumors LC may be more effective than SC in assuring local control. METHODS AND MATERIALS: A systematic review and meta-analysis of the randomized trials comparing SC with LC was performed to test the hypothesis that for low-lying tumors, LC is superior to SC in reducing the risk of local failure. RESULTS: The systematic search identified 4 trials including, in total, 421 patients with tumors <5 cm from the anal verge; 221 were randomized to SC and 200 to LC. The meta-analysis showed that the difference in local failure rate between SC and LC was insignificant; the pooled odds ratio was 0.87, 95% confidence interval 0.53 to 1.44, P = .59. Heterogeneity between trials was insignificant; I2 = 0.0%, P = .47. CONCLUSIONS: Our meta-analysis does not support the notion that LC given before total mesorectal excision is superior to SC in reducing the risk of local failure in low-lying tumors.
引用
- Socha J, Kairevice L, Kępka L, et al. Should Short-Course Neoadjuvant Radiation Therapy Be Applied for Low-Lying Rectal Cancer? A Systematic Review and Meta-Analysis of the Randomized Trials. Int J Radiat Oncol Biol Phys. 2020. PMID: 32634546. doi:10.1016/j.ijrobp.2020.06.077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。